245 First Street, 4th Floor
Magenta is focused on improving the patient experience in transplant medicine, with the goal of bringing this lifesaving procedure to more patients. Over the past 50 years, stem cell transplantation has been used in more than 1M patients worldwide. It is currently the only treatment with the potential to cure some of the most devastating hematologic cancers and autoimmune diseases. Despite the increased use and clinical advancements over the past several decades, stem cell transplant remains a high-risk last-resort therapeutic option due to the toxicity and potential long-term side effects.
Founder and CEO: Jason Gardner
COO: Bastiano Sanna
CSO: Michael Cooke
VP, Head of Business Development: Christina Isacson
Please click here for Magenta's job opportunities.
Please click here for Magenta's science.